NB
GSK icon

Nicolet Bankshares’s GSK GSK Stock Holding History

Nicolet Bankshares’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Sell
44,504
-1,008
-2% -$53.3K 0.07% 185
2026
Q1 		$2.53M Buy
45,512
+26,867
+144% +$1.46M 0.09% 165
2025
Q4 		$914K Sell
18,645
-7,567
-29% -$353K 0.15% 105
2025
Q3 		$1.13M Buy
26,212
+1,093
+4% +$42.7K 0.18% 90
2025
Q2 		$965K Buy
25,119
+1,126
+5% +$43K 0.17% 92
2025
Q1 		$929K Sell
23,993
-1,240
-5% -$45.4K 0.19% 90
2024
Q4 		$853K Sell
25,233
-1,569
-6% -$56.5K 0.2% 98
2024
Q3 		$1.1M Buy
26,802
+670
+3% +$27.4K 0.27% 83
2024
Q2 		$1.01M Sell
26,132
-973
-4% -$40.9K 0.25% 86
2024
Q1 		$1.16M Buy
27,105
+289
+1% +$11.9K 0.29% 83
2023
Q4 		$994K Buy
26,816
+1,903
+8% +$68.3K 0.27% 89
2023
Q3 		$903K Sell
24,913
-9,791
-28% -$348K 0.28% 82
2023
Q2 		$801K Buy
34,704
+25,402
+273% +$911K 0.23% 90
2023
Q1 		$331K Sell
9,302
-2,105
-18% -$73.6K 0.11% 146
2022
Q4 		$401K Buy
+11,407
New +$380K 0.14% 122

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nicolet Bankshares's GSK Position: Q2 2026 in Review

Nicolet Bankshares reduced its GSK (GSK) stake by 2.2% in Q2 2026, selling an estimated $53.3K and leaving 44,504 shares worth $2.35M. The position accounts for 0.07% of the portfolio, ranked #185.

Nicolet Bankshares first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.53M in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Nicolet Bankshares held 44,504 shares of GSK worth $2.35M as of Q2 2026.
  • Nicolet Bankshares sold 1,008 GSK shares in Q2 2026, an estimated $53.3K.
  • GSK made up 0.07% of Nicolet Bankshares's portfolio in Q2 2026, its #185 holding.
  • Nicolet Bankshares first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • Nicolet Bankshares's GSK position peaked at $2.53M in Q1 2026.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.